Kenji Maeda

19.6k total citations
343 papers, 11.8k citations indexed

About

Kenji Maeda is a scholar working on Infectious Diseases, Nephrology and Molecular Biology. According to data from OpenAlex, Kenji Maeda has authored 343 papers receiving a total of 11.8k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Infectious Diseases, 68 papers in Nephrology and 57 papers in Molecular Biology. Recurrent topics in Kenji Maeda's work include HIV Research and Treatment (48 papers), HIV/AIDS drug development and treatment (42 papers) and Dialysis and Renal Disease Management (42 papers). Kenji Maeda is often cited by papers focused on HIV Research and Treatment (48 papers), HIV/AIDS drug development and treatment (42 papers) and Dialysis and Renal Disease Management (42 papers). Kenji Maeda collaborates with scholars based in Japan, United States and Belgium. Kenji Maeda's co-authors include Toshio Miyata, Hiroaki Mitsuya, Toru Shinzato, Hiroko Odani, Kiyoshi Kurokawa, Yuichiro Iida, Toshimitsu Niwa, Yoshinari Yasuda, Yoshiyasu Iida and Yoshihiro Matsumoto and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Kenji Maeda

323 papers receiving 11.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenji Maeda Japan 56 2.6k 2.4k 2.4k 1.5k 1.5k 343 11.8k
Yoshitaka Isaka Japan 53 4.1k 1.6× 546 0.2× 4.1k 1.8× 386 0.3× 544 0.4× 395 12.2k
Thomas M. Coffman United States 72 6.4k 2.4× 496 0.2× 2.2k 0.9× 596 0.4× 4.5k 3.0× 253 20.3k
Hidenori Koyama Japan 68 5.9k 2.2× 1.0k 0.4× 1.8k 0.8× 319 0.2× 1.8k 1.2× 414 15.1k
Francesco Chiarelli Italy 63 2.1k 0.8× 1.0k 0.4× 577 0.2× 360 0.2× 4.4k 3.0× 629 15.9k
Fabrizio Veglia Italy 60 1.6k 0.6× 148 0.1× 1.7k 0.7× 580 0.4× 1.3k 0.9× 291 14.5k
Jean‐Paul Cristol France 56 2.7k 1.0× 641 0.3× 2.3k 1.0× 224 0.1× 2.5k 1.7× 427 12.6k
Béatrice Descamps‐Latscha France 44 1.7k 0.6× 1.2k 0.5× 2.7k 1.1× 183 0.1× 596 0.4× 97 9.2k
Fuu‐Jen Tsai Taiwan 55 5.8k 2.2× 379 0.2× 313 0.1× 496 0.3× 724 0.5× 520 13.9k
Assam El‐Osta Australia 55 7.5k 2.8× 711 0.3× 453 0.2× 218 0.1× 1.2k 0.8× 202 12.1k
Martine Laville France 65 5.7k 2.2× 414 0.2× 683 0.3× 246 0.2× 2.3k 1.6× 335 15.8k

Countries citing papers authored by Kenji Maeda

Since Specialization
Citations

This map shows the geographic impact of Kenji Maeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Maeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Maeda more than expected).

Fields of papers citing papers by Kenji Maeda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Maeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Maeda. The network helps show where Kenji Maeda may publish in the future.

Co-authorship network of co-authors of Kenji Maeda

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Maeda. A scholar is included among the top collaborators of Kenji Maeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Maeda. Kenji Maeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsuda, Kouki, Ryusho Kariya, Kenji Maeda, & Seiji Okada. (2024). Evaluating the Use of Sacran, a Polysaccharide Isolated from Aphanothece sacrum, as a Possible Microbicide for Preventing HIV-1 Infection. Viruses. 16(9). 1501–1501.
2.
Matsuda, Kouki & Kenji Maeda. (2024). HIV Reservoirs and Treatment Strategies toward Curing HIV Infection. International Journal of Molecular Sciences. 25(5). 2621–2621. 10 indexed citations
3.
Monde, Kazuaki, Kenji Sugata, Benjy J.Y. Tan, et al.. (2024). HIV-Tocky system to visualize proviral expression dynamics. Communications Biology. 7(1). 344–344. 4 indexed citations
4.
Ishii, Takahiro, Takuya Kobayakawa, Kouki Matsuda, et al.. (2023). Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity. European Journal of Medicinal Chemistry. 256. 115449–115449. 8 indexed citations
5.
Amada, Naoki, et al.. (2023). Synergistic anti‐depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice. Neuropsychopharmacology Reports. 43(1). 132–136. 7 indexed citations
6.
Yamamoto, Shohei, Ami Fukunaga, Akihito Tanaka, et al.. (2022). Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine. Vaccine. 40(13). 1924–1927. 20 indexed citations
7.
Khor, Seik‐Soon, Yosuke Omae, Junko S. Takeuchi, et al.. (2022). An Association Study of HLA with the Kinetics of SARS-CoV-2 Spike Specific IgG Antibody Responses to BNT162b2 mRNA Vaccine. Vaccines. 10(4). 563–563. 9 indexed citations
8.
Ishikane, Masahiro, Mari Terada, Akihiro Matsunaga, et al.. (2022). Antibody responses after two doses of SARS-CoV-2 mRNA-1273 vaccine in an individual with history of COVID-19 re-infection. International Journal of Infectious Diseases. 119. 18–20.
9.
Yamamoto, Shohei, Kenji Maeda, Kouki Matsuda, et al.. (2021). Coronavirus Disease 2019 (COVID-19) Breakthrough Infection and Post-Vaccination Neutralizing Antibodies Among Healthcare Workers in a Referral Hospital in Tokyo: A Case-Control Matching Study. Clinical Infectious Diseases. 75(1). e683–e691. 33 indexed citations
10.
Ishikane, Masahiro, Mari Terada, Akihiro Matsunaga, et al.. (2021). Asymptomatic COVID-19 re-infection in a Japanese male by elevated half-maximal inhibitory concentration (IC50) of neutralizing antibodies. Journal of Infection and Chemotherapy. 27(7). 1063–1067. 7 indexed citations
11.
Takamatsu, Yuki, Masaki Imai, Kenji Maeda, et al.. (2021). Highly Neutralizing COVID-19 Convalescent Plasmas Potently Block SARS-CoV-2 Replication and Pneumonia in Syrian Hamsters. Journal of Virology. 96(4). e0155121–e0155121. 16 indexed citations
12.
Maeda, Kenji, et al.. (2019). The glucagon-like peptide 1 receptor agonist liraglutide attenuates placental ischemia-induced hypertension. American Journal of Physiology-Heart and Circulatory Physiology. 318(1). H72–H77. 18 indexed citations
13.
Maeda, Kenji, et al.. (2009). A decision analysis of the effectiveness of the pediatric telephone triage program in Japan.. PubMed. 3(5). 184–90. 4 indexed citations
14.
Hamada, Akinobu, Tristan M. Sissung, Douglas K. Price, et al.. (2008). Effect of SLCO1B3 Haplotype on Testosterone Transport and Clinical Outcome in Caucasian Patients with Androgen-Independent Prostatic Cancer. Clinical Cancer Research. 14(11). 3312–3318. 153 indexed citations
15.
Maeda, Kenji, Debananda Das, Hirotomo Nakata, et al.. (2006). Structural and Molecular Interactions of CCR5 Inhibitors with CCR5. Journal of Biological Chemistry. 281(18). 12688–12698. 130 indexed citations
16.
17.
Maeda, Kenji & Takahiro Shinzato. (1996). Advanced glycation end-products in diabetes mellitus and renal failure. Oxford University Press eBooks. 1 indexed citations
18.
Maeda, Kenji, et al.. (1995). STUDY ON THE APPLICATION OF NEW CONCEPT FOR KNEADING CONCRETE. Journal of Structural and Construction Engineering (Transactions of AIJ). 60(473). 39–46. 1 indexed citations
19.
Aoyagi, Takahiko, Katsumi Eguchi, Munetoshi Nakashima, et al.. (1993). Immunolocalization of Adhesion Molecules in Rheumatoid and Osteoarthritic Synovial Tissues. Nagasaki University's Academic Output SITE (Nagasaki University). 38(2). 62–70. 1 indexed citations
20.
Miyata, Toshio, Osamu Oda, Reiko Inagi, et al.. (1993). beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis.. Journal of Clinical Investigation. 92(3). 1243–1252. 348 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshitaka Isaka Breakdown of academic impact, for papers by Thomas M. Coffman Breakdown of academic impact, for papers by Hidenori Koyama Breakdown of academic impact, for papers by Francesco Chiarelli Breakdown of academic impact, for papers by Fabrizio Veglia Breakdown of academic impact, for papers by Jean‐Paul Cristol Breakdown of academic impact, for papers by Béatrice Descamps‐Latscha Breakdown of academic impact, for papers by Fuu‐Jen Tsai Breakdown of academic impact, for papers by Assam El‐Osta Breakdown of academic impact, for papers by Martine Laville
Rankless by CCL
2026